KIA
GSK icon

KLR Investment Advisors’s GSK GSK Stock Holding History

KLR Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$701K Buy
+17,263
New +$712K 0.51% 49
2023
Q4 		– Sell
-12,745
Closed -$457K – 188
2023
Q3 		$457K Sell
12,745
-2,432
-16% -$86.3K 0.42% 75
2023
Q2 		$546K Buy
15,177
+1,896
+14% +$68K 0.45% 58
2023
Q1 		$476K Buy
+13,281
New +$465K 0.42% 75

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KLR Investment Advisors's GSK Position: Q1 2024 in Review

KLR Investment Advisors opened a new position in GSK (GSK) in Q1 2024: 17,263 shares worth $701K. The stake represents 0.51% of the portfolio and ranks #49 among its holdings. This is a return to the name: KLR Investment Advisors previously reported a position in GSK as recently as Q3 2023.

KLR Investment Advisors first reported a position in GSK in Q1 2023 and has held it in 4 quarters since. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • KLR Investment Advisors held 17,263 shares of GSK worth $701K as of Q1 2024.
  • GSK was a new KLR Investment Advisors position in Q1 2024.
  • GSK made up 0.51% of KLR Investment Advisors's portfolio in Q1 2024, its #49 holding.
  • KLR Investment Advisors first reported a position in GSK in Q1 2023 and has held it in 4 quarters since.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on KLR Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.